Federal Register #Investigation No. 731-TA-1012 (Fourth Review)

USITC Review of Antidumping Duty on Fish Fillets and Section 337 Investigation of Lidocaine Patches

This notice from the U.S. International Trade Commission (USITC) covers two distinct regulatory actions: - Expedited Five-Year Review of Antidumping Duty Order - The USITC is conducting a review to determine if revoking the antidumping duty order on frozen fish fillets from Vietnam would likely result in continued or recurring material injury to the U.S. industry. - No specific OEMs, vendors, or product quantities are involved, as this is a regulatory review, not a procurement. - Section 337 Investigation on Topical Lidocaine Patches - The USITC has instituted an investigation into alleged patent infringement of over-the-counter topical lidocaine patches, focusing on U.S. Patent No. 12,109,181. - The complainant is J.A.R. Laboratories LLC, seeking exclusion and cease and desist orders against multiple respondents. - Named respondents include Veridian Healthcare LLC, Perrigo Company plc, Opella Healthcare Group SAS, Chattem, Inc., Hisamitsu Pharmaceutical Co., Inc., Reckitt Benckiser Group PL, and related entities. - The investigation targets topical lidocaine patches alleged to infringe the specified patent. - Key Details - No procurement of goods or services is taking place; the actions are regulatory and investigatory in nature. - The USITC Office of Investigations is the lead office. - The primary location for these actions is the USITC headquarters in Washington, DC. - The Section 337 investigation may impact the market for topical lidocaine patches, with potential exclusion orders affecting importers and manufacturers. - No purchase quantities, part numbers, or contract values are specified.

Description

The U.S. International Trade Commission has announced the scheduling of an expedited five-year review to determine whether revocation of the antidumping duty order on frozen fish fillets from Vietnam would likely lead to continuation or recurrence of material injury within a reasonably foreseeable time. This review follows the Commission's determination that the domestic interested party response was adequate and the respondent interested party response was inadequate, leading to an expedited review rather than a full review. The process includes opportunities for written comments and aims to assess the impact of potentially revoking the existing antidumping duty order.

View original listing